#01【非常好】010Meta分析：从理论到实践.pptVIP

* And abdominal pain * And abdominal pain * And abdominal pain * But we shall take a critical review on this meta-analysis, we will find Randomized non-randomized trials included, Small sample size of each trial (n100) ,Trials with methodological limitations No trial addressed the efficacy in high-risk pts * Contrary to previous study, in this meta-analysis, we had a much bigger Sample size, and we Only included randomized trials and excluded non-randomized trials, finally we included trials dealing with High-risk pts * Contrary to previous study, in this meta-analysis, we had a much bigger Sample size, and we Only included randomized trials and excluded non-randomized trials, finally we included trials dealing with High-risk pts * * * we got a similar conclusion in somatostatin’s preventive effect on Hyperamylasemia * * * * * Then what is about octreotide ? Only One small-scale RCT of octreotide on high-risk patients failed to support its efficacy, and Subsequent large-scale RCTs of octreotide on average-risk patients produced positive results, so we are quite interested on Future large-scale RCTs of octreotide on high-risk patients * * H:\Meta-analysis\Antibiotic therapy预防SAP的继发感染和死亡\RCT\Prophylactic antibiotics can not reduce infected pancreatic necrosis and mortality.ppt * Good morning, everyone, thanks for the opportunity to be here to present our research. And I am going to talk about Allopurinol in the prevention of post-ERCP pancreatitis. * Good morning, everyone, thanks for the opportunity to be here to present our research. And I am going to talk about Allopurinol in the prevention of post-ERCP pancreatitis. * H:\Meta-analysis\Antibiotic therapy预防SAP的继发感染和死亡\RCT\Prophylactic antibiotics can not reduce infected pancreatic necrosis and mortality.ppt * Among these major complications, acute pancreatitis is the most common serious complication of ERCP. It accounted for more than one-half of complications of ERCP in several large studies. 2/3 malpractice cl